847
Co-infection with Hepatitis C Virus Increases Lymphocyte Apoptosis in HIV-infected Patients
Marina Nuñez*, V Soriano, M López, C Ballesteros, A Cascajero, J González-Lahoz, and J Benito
Hosp Carlos III, Madrid, Spain
Background: The role of hepatitis C virus (HCV) co-infection on
CD4+ T cell depletion is not well known. Apoptosis has been proposed
as a mechanism for CD4 depletion in HIV infection. In co-infected T cells, HCV
and HIV might act synergistically, enhancing lymphocyte apoptosis.
Methods: HIV+ subjects without antiretroviral
therapy for at least 6 months were randomly selected from our HIV clinic.
Plasma HIV RNA and HCV RNA levels, as well as CD4 counts were recorded. HCV+
patients were defined as those having detectable plasma HCV RNA. Levels of
apoptosis in different subsets of CD4+ and CD8+ T cells
were examined ex vivo in whole blood
by Annexin V binding using 4-color flow cytometry. Multivariate linear regression analysis was
performed to assess the influence of HCV on levels of apoptosis.
Results: We analyzed 61 patients: 31 HIV-mono-infected and 30 HIV/HCV-co-infected.
Mean age and HIV RNA levels were comparable in mono-infected and co-infected
patients, whereas the mean CD4 count tended to be lower in the co-infected group
(578 vs 452 cells/mm3; p = 0.07). Memory (CD45RO+)
and naïve (CD45RA+CD62L+) subsets of CD4+ and
CD8+ T lymphocytes, as well as their level of activation (CD38+)
were similar in both groups. Co-infected patients showed significantly higher
levels of apoptosis in the naïve subset of CD4+ T cells and in the
naive and memory subsets of CD8+ T cells when compared to HIV-mono-infected
patients. After adjusting for age, CD4 counts and HIV RNA levels, HCV co-infection
remained significantly associated with higher levels of apoptosis in naive CD4+
T cells (b= 0.29; 95%CI 0.2 to 6.4; p = 0.04), naive CD8+ T cells
(b = 0.32; 95%CI 0.53 to 9.2; p = 0.03), and memory CD8+ T
cells (b = 0.37; 95%CI 1.3 to 7.6; p = 0.006).
Conclusions: HCV co-infection is associated with increased
apoptosis of T lymphocytes in HIV+ patients, which could explain a
more rapid CD4 decline and an impaired CD4 recovery following initiation of
HAART in co-infected patients.
|